Predicted protein targets (top 4)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | AGTR2 | P50052 | 1/20 | 0.49 |
| ▸ | AGTR1 | P30556 | 3/20 | 0.49 |
| ▸ | PPARG | P37231 | 1/20 | 0.47 |
| ▸ | LTB4R2 | Q9NPC1 | 1/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30539277 | 1.00 | AGTR2 (0.49) | AGTR2AGTR1PPARGLTB4R2 | |
| SCHEMBL30539225 | 1.00 | AGTR2 (0.49) | AGTR2AGTR1PPARGLTB4R2 | |
| SCHEMBL13465241 | 0.89 | AGTR2 (0.54) | AGTR2AGTR1PPARG | |
| SCHEMBL18088504 | 0.84 | AGTR2 (0.56) | AGTR2 | |
| SCHEMBL18087887 | 0.83 | AGTR2 (0.59) | AGTR2 | |
| SCHEMBL4935797 | 0.83 | AGTR1 (0.44) | AGTR2AGTR1PPARGLTB4R2 | |
| SCHEMBL684043 | 0.82 | AGTR2 (0.59) | AGTR2 | |
| SCHEMBL683370 | 0.82 | AGTR2 (0.61) | AGTR2AGTR1PPARGLTB4R2 | |
| SCHEMBL9882910 | 0.82 | AGTR2 (0.55) | AGTR2 | |
| Azilsartan SCHEMBL167538 | 0.81 | AGTR2 (0.72) | AGTR2AGTR1PPARGLTB4R2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-113466360-B | Azilsartan 6 related substance detection method | 珠海润都制药股份有限公司 | 2023-03-03 | — | — | CN | claimed |
| CN-113466360-A | Azilsartan 6 related substance detection method | 珠海润都制药股份有限公司 | 2021-10-01 | — | — | CN | claimed |
| CN-116807986-A | Azilsartan amlodipine tablet and preparation method thereof | 北京百奥药业有限责任公司 | 2023-09-29 | — | — | CN | disclosed |